MKI67 and breast cancer: To better explore the relationship between the clinical features of breast cancer and sentinel lymph node tumor burden, which can rule out the influence of other factors, including age, molecular subtype, Ki-67, neoadjuvant chemotherapy, menopause, and tumor site, a univariate logistic regression analysis was performed.